Snowball logo
logo
VYGR_logo

Voyager Therapeutics, Inc

VYGR β€’ NASDAQ
$1.75+$0.01Β  (0.57%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
37.4140.912508040.3734.46
COGS
73.796.19192.174.731132.3-
Gross Profit
37.4140.91157.880(91.9)34.46
Operating Expenses & Income
Operating Income
(73.62)(50.84)122(83.29)(131.8)(117.2)
Total Operating Expenses
11191.7435.82163.339.94151.6
R&D Expenses
73.7960.7692.17127.4134.7118.5
Selling General & Admin Expenses
37.2530.9835.8235.9236.4433.19
Earnings from Continuing Operations
Interest Expense
(0.39)(1.792)----
Interest Income
0.334----5.825
Income Tax Expense
(5.165)0.0161.4080.6650.1440.126
Net Income
Net Income
(66.03)(46.41)132.3(65)(119.7)(107.7)
Supplemental
EBIT
(73.62)(50.84)133.7(64.34)(119.6)(107.6)
EBITDA
(68.45)(44.65)138.2(59.61)(115.5)(103.8)
In millions of USD, except % and values per 1 share